Vertex to buy Crinetics in $10 billion deal
06/07/2026 21:08
Vertex to buy Crinetics in $10 billion deal July 6 (Reuters) - Vertex Pharmaceuticals VRTX.O will buy Crinetics Pharmaceuticals CRNX.O for a total equity value of about $10 billion, the companies said on Monday.
(Reporting by Puyaan Singh in Bengaluru; Editing by Jonathan Ananda)
Recent news on Vertex Pharmaceuticals Incorporated
See all newsBrief: Vertex Appoints Daniel Brennan To Its Board Of Directors
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Vertex rises after kidney disease drug shows promise in mid-stage study
Brief: Vertex Pharmaceuticals Incorporated Says Inaxaplin Reduces UACR By -42.7% At Week 13 In AMKD With Modest Proteinuria